# WO-09 product readiness

Status: PARTIAL.

Branch: `codex/pccare-diagnostic-qualification-recovery-planning`.
Baseline: `5ac4c4d5a4420bba9b9a1d2bbd8d3de12047c96a`.
CI source: `888ec1e8de1fe4fc2bcb7b2217e544d20dc929e7`.
Phase 1: NO-GO.

## Qualification boundaries

| Area | Status | Evidence and remaining condition |
|---|---|---|
| Independent reference pipeline | PARTIAL | CI capture and SDK analysis determine the observed status. |
| Actual CPU accuracy | PARTIAL | Only qualified, aligned CPU trials can supply truth. |
| Memory and disk accuracy | NOT TESTED | Independent pressure ground truth is absent. |
| Process attribution | PARTIAL | Synthetic lifetime and I/O selection pass. Cross-parser joins remain incomplete. |
| Disk identity | PARTIAL | Two local mappings agree. Persistent application identity remains incomplete. |
| Recovery plans | PASS | Compiled review contracts and evidence gates pass automated tests. |
| Dry Run | PASS | Four synthetic previews record zero system mutations. |
| Live GUI | NOT TESTED | Headless lifecycle and XAML compilation are separate evidence. |
| Existing security regression | PASS | Local application and SecurityLab results are preserved. |
| Official product release | BLOCKED | Phase 1 production signing and installation requirements remain unmet. |

## Next implementation priorities

1. Resolve remaining independent CPU sampling gaps without relaxing the predeclared acceptance criteria.
2. Qualify memory pressure with independent commit, paging, and available-memory evidence.
3. Qualify device I/O pressure with stable device mapping and independent latency measurements.
4. Join independent process lifetimes using private local correlation data.
5. Measure contribution errors without publishing process names or command lines.
6. Repeat CPU trials on representative hardware and counterbalanced trial orders.
7. Execute live GUI lifecycle, high-DPI, keyboard, and screen-reader tests.
8. Add evidence contracts for startup, cache, space, component, update, and service review plans.
9. Complete production signing and isolated installation qualification before release.

User-approved recovery execution is a later work order.
It requires a selected target, explicit consent, saved state, reversible actions, and before/after measurements.
Current plans permit review only. ExpectedEffect remains Unknown.
WO-09 remains PARTIAL until the incomplete qualification areas have suitable evidence.

## Final evidence decision

Windows CI [38105566632](https://github.com/scarlel96-design/PC-Care/actions/runs/38105566632) passed on `888ec1e8de1fe4fc2bcb7b2217e544d20dc929e7`.
Application regression: 915 PASS, 111 SKIP, zero FAIL.
Performance regression: 146 PASS, included in the application count.
Update regression: 128 PASS, included in the application count.
SecurityLab: 36 PASS, separate project.
SDK conversion fixture: ten PASS, separate from application unit tests.
The Release build reported zero warnings and zero errors.

All six independent CPU references remain unqualified because SDK sampling gaps persist.
Precision and Recall remain null. Unknown is 18 resource-category decisions.
The pipeline can capture and analyze traces. Independent diagnostic qualification remains PARTIAL.
Live GUI and representative low-end hardware validation remain NOT TESTED.
Phase 1 stays NO-GO. This branch has no main merge or official release.
